These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 12665314

  • 1. Tc-99m MIBI SPECT in detecting metastatic papillary thyroid carcinoma in patients with elevated human serum thyroglobulin levels but negative I-131 whole body scan.
    Hsu CH, Liu FY, Yen RF, Kao CH.
    Endocr Res; 2003 Feb; 29(1):9-15. PubMed ID: 12665314
    [Abstract] [Full Text] [Related]

  • 2. Technetium-99m tetrofosmin single photon emission computed tomography to detect metastatic papillary thyroid carcinoma in patients with elevated human serum thyroglobulin levels but negative I-131 whole body scan.
    Wu HS, Liu FY, Huang WS, Liu YC, Chang CT, Kao CH.
    Clin Radiol; 2003 Oct; 58(10):787-90. PubMed ID: 14521888
    [Abstract] [Full Text] [Related]

  • 3. F18-fluorodeoxyglucose positron emission tomography in detecting metastatic papillary thyroid carcinoma with elevated human serum thyroglobulin levels but negative I-131 whole body scan.
    Hung MC, Wu HS, Kao CH, Chen WK, Changlai SP.
    Endocr Res; 2003 May; 29(2):169-75. PubMed ID: 12856803
    [Abstract] [Full Text] [Related]

  • 4. Comparison of FDG-PET and technetium-99m MIBI SPECT to detect metastatic cervical lymph nodes in well-differentiated thyroid carcinoma with elevated serum HTG but negative I-131 whole body scan.
    Wu HS, Huang WS, Liu YC, Yen RF, Shen YY, Kao CH.
    Anticancer Res; 2003 May; 23(5b):4235-8. PubMed ID: 14666632
    [Abstract] [Full Text] [Related]

  • 5. Detecting metastatic neck lymph nodes in papillary thyroid carcinoma by 18F-2-deoxyglucose positron emission tomography and Tc-99m tetrofosmin single photon emission computed tomography.
    Wu YJ, Wu HS, Yen RF, Shen YY, Kao CH.
    Anticancer Res; 2003 May; 23(3C):2973-6. PubMed ID: 12926147
    [Abstract] [Full Text] [Related]

  • 6. Clinical importance of technetium-99m-methoxyisobutylisonitrile (MIBI) scintigraphy in differentiated thyroid carcinoma patients with elevated thyroglobulin levels and negative I-131 scanning results.
    Küçük NO, Külak HA, Aras G.
    Ann Nucl Med; 2006 Jul; 20(6):393-7. PubMed ID: 16922467
    [Abstract] [Full Text] [Related]

  • 7. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
    Sergieva S, Hadjieva T, Doldurova M, Stefanova S, Dudov A.
    J BUON; 2006 Jul; 11(4):511-8. PubMed ID: 17309186
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human TSH changes the multidisciplinary approach to patients with differentiated thyroid carcinoma. Two-year experience.
    Giusti M, Zoccola R, Guazzini B, Molinari E, Valenti S, Villa G, Bertolazzi L, Minuto F.
    Minerva Endocrinol; 2003 Sep; 28(3):191-203. PubMed ID: 14605601
    [Abstract] [Full Text] [Related]

  • 9. The Value of 99mTc-MIBI SPECT/CT in the Postoperative Assessment of Patients with Differentiated Thyroid Carcinoma.
    Okudan B, Seven B, Gülaldı NCM, Çapraz M, Açıkgöz Y.
    Curr Med Imaging; 2022 Sep; 18(4):404-408. PubMed ID: 34749623
    [Abstract] [Full Text] [Related]

  • 10. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
    Iwata M, Kasagi K, Misaki T, Matsumoto K, Iida Y, Ishimori T, Nakamoto Y, Higashi T, Saga T, Konishi J.
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
    [Abstract] [Full Text] [Related]

  • 11. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery.
    Rubello D, Mazzarotto R, Casara D.
    Eur J Nucl Med; 2000 Apr; 27(4):431-40. PubMed ID: 10805117
    [Abstract] [Full Text] [Related]

  • 12. Radioiodine whole-body scans, thyroglobulin levels, 99mTc-MIBI scans and computed tomography: results in patients with lung metastases from differentiated thyroid cancer.
    Küçük ON, Gültekin SS, Aras G, Ibiş E.
    Nucl Med Commun; 2006 Mar; 27(3):261-6. PubMed ID: 16479246
    [Abstract] [Full Text] [Related]

  • 13. Compare FDG-PET and Tc-99m tetrofosmin SPECT to detect metastatic thyroid carcinoma.
    Chen YK, Liu FY, Yen RF, Kao CH.
    Acad Radiol; 2003 Aug; 10(8):835-9. PubMed ID: 12945916
    [Abstract] [Full Text] [Related]

  • 14. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P, Gallowitsch HJ.
    Acta Med Austriaca; 1996 Aug; 23(1-2):69-75. PubMed ID: 8767519
    [Abstract] [Full Text] [Related]

  • 15. Technetium-99m methoxyisobutylisonitrile imaging in the follow-up of differentiated thyroid carcinoma.
    Sriprapaporn J, Toopmongkol C, Satayaban B, Chantamoon N.
    Ann Acad Med Singap; 2002 Mar; 31(2):195-8. PubMed ID: 11957557
    [Abstract] [Full Text] [Related]

  • 16. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P, Kohlfürst S.
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [Abstract] [Full Text] [Related]

  • 17. Clinical utility of technetium-99m methoxisobutylisonitrile imaging in differentiated thyroid carcinoma: comparison with thallium-201 and iodine-131 Na scintigraphy, and serum thyroglobulin quantitation.
    Dadparvar S, Chevres A, Tulchinsky M, Krishna-Badrinath L, Khan AS, Slizofski WJ.
    Eur J Nucl Med; 1995 Nov; 22(11):1330-8. PubMed ID: 8575487
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic capabilities of I-131, TI-201, and Tc-99m-MIBI scintigraphy for metastatic differentiated thyroid carcinoma after total thyroidectomy.
    Fujie S, Okumura Y, Sato S, Akaki S, Katsui K, Himei K, Takemoto M, Kanazawa S.
    Acta Med Okayama; 2005 Jun; 59(3):99-107. PubMed ID: 16049563
    [Abstract] [Full Text] [Related]

  • 19. Clinical Value of 99mTc-3PRGD2 SPECT/CT in Differentiated Thyroid Carcinoma with Negative 131I Whole-Body Scan and Elevated Thyroglobulin Level.
    Gao R, Zhang GJ, Wang YB, Liu Y, Wang F, Jia X, Liang YQ, Yang AM.
    Sci Rep; 2018 Jan 11; 8(1):473. PubMed ID: 29323252
    [Abstract] [Full Text] [Related]

  • 20. Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm?
    Dietlein M, Scheidhauer K, Voth E, Theissen P, Schicha H.
    Nuklearmedizin; 1998 Jan 11; 37(1):12-7. PubMed ID: 9467164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.